Elevance Health Q4 EPS Beats by 7.3% Despite Membership Decline
Elevance Health reported Q4 adjusted EPS of $3.33, beating the consensus estimate by 7.3% thanks to robust premium growth. Segment performance was mixed, with Carelon division surging revenues and Health Benefits boosting Medicare Advantage yields, but overall medical membership declined and expenses rose.
1. Q4 Earnings Beat
Elevance Health delivered fourth-quarter 2025 adjusted EPS of $3.33, surpassing the consensus estimate by 7.3% primarily on strong premium revenue gains in its insurance offerings.
2. Segment Performance and Offsets
The Carelon division posted a robust revenue surge driven by buyouts and expanded risk-based services, while the Health Benefits unit saw higher premium yields and Medicare Advantage membership growth; however, a drop in overall medical membership and elevated operating expenses partially offset these gains.